Neuropsychopharmacology
- High hopes, hard realities: cannabidiol shows no acute effects in youth with alcohol use disorder5 months ago
- Targeting inhibitory control in youth irritability: challenges and opportunities5 months ago
- Targeting depression circuitry with H1 coil Transcranial Magnetic Stimulation: a retrospective circuit mapping study5 months ago
- Circulating endocannabinoids in children and adolescents: associations with anxiety and the impact of selective serotonin reuptake inhibitors5 months ago
- Anti-seizure effects of WS-3, a TRPM8 agonist, on focal onset seizure mouse model via reduction of extracellular glutamate levels5 months ago
- Using causal network mapping to clarify pre-clinical brain stimulation results5 months ago
- Neurobiology of resilience to early life stress5 months ago
Journal of Psychopharmacology
- Exploring the impact of MDMA and oxytocin ligands on anxiety and social responses: A comprehensive behavioural and molecular study in the zebrafish model9 months ago
- Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study9 months ago
- A randomized, placebo-controlled, double-blind, pilot study of cannabis-related driving impairment assessed by driving simulator and self-report9 months ago
- Lifetime classic psychedelic use and headaches: A cross-sectional study9 months ago
- A three-stage strategy for conducting an experimental investigation: A recommendation to improve the reproducibility of reported conclusions9 months ago
- Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study9 months ago
- Acute subanesthetic ketamine-induced effects on the mismatch negativity and their relationship to early and sustained treatment response in major depressive disorder9 months ago
European Neuropsychopharmacology
- Low dose oral ketamine treatment on post-traumatic stress disorder (PTSD) (OKTOP): An open-label pilot study10 months ago
- Preliminary evidence should be treated as such: Response to “Is creatine useful as adjuvant in cognitive-behavioural therapy for depression?”10 months ago
- MiRNAs and extracellular vesicles in psychiatry: Potential biomarkers, therapeutic advances, and animal models11 months ago
- 3D imaging and geometric morphometrics of facial dysmorphology and asymmetry indicate gestational timings of dysmorphogenesis in schizophrenia and bipolar disorder11 months ago
- Disease-wide association study uncovers disease continuum network of unipolar depression11 months ago
- Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis12 months ago
- Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach12 months ago